🔴 LIVE: The Secrets of ProPicks AI Success Revealed + November’s List FREEWatch Now

PRESS DIGEST- New York Times business news - Nov 5

Published 2015-11-05, 12:23 a/m
© Reuters.  PRESS DIGEST- New York Times business news - Nov 5
EXPE
-
BHC
-
AWAY
-
META
-

Nov 5 (Reuters) - The following are the top stories on the
New York Times business pages. Reuters has not verified these
stories and does not vouch for their accuracy.

- Expedia Inc EXPE.O said it had agreed to acquire
HomeAway Inc AWAY.O for $3.9 billion, adding vacation rentals
to its wide swath of online travel booking options.

- Facebook Inc FB.O on Wednesday posted another quarter of
robust revenue growth - up 41 percent in the third quarter from
a year earlier, to $4.5 billion - fueled by its mobile
advertising business and an increase in daily users.

- A Senate committee has started an investigation into the
large drug price increases by Turing Pharmaceuticals and three
other companies such as Valeant Pharmaceuticals (N:VRX) Inc VRX.TO ,
responding to public concern about escalating prices for
critical medicines.

- After a long period of quiet, the price of the virtual
currency Bitcoin is surging again as signs of interest from
China and Wall Street have helped kick off a new speculative
frenzy.

- The U.S. Federal Reserve could raise its benchmark
interest rate in December as long as economic growth continues,
two senior Fed officials said on Wednesday, hammering that
message in repeated public remarks.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.